Vickers Vantage Corp. I (SCLX)

Number of records: 14
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
26-Jun-24 9:31 PM
View: 
Followwill Dorman
Director
Vickers Vantage Corp. I (SCLX) 26-Jun-24Option Exercise 1,000$1.37$1,370.00333%
0.3K to 1.3K
20-Jun-24 4:43 PM
View: 
Shah Jaisim
See Remarks
Director
Vickers Vantage Corp. I (SCLX) 20-Jun-24Option Exercise 14,000$1.73$24,220.007%
189.22K to 203.22K
20-Jun-24 6:07 PM
View: 
Wu Yue Alexander
Director
Vickers Vantage Corp. I (SCLX) 20-Jun-24Option Exercise 5,000$1.41$7,050.00100%
0 to 5.0K
20-Jun-24 4:49 PM
View: 
Chun Jay
Director
Vickers Vantage Corp. I (SCLX) 20-Jun-24Option Exercise 5,000$1.41$7,050.005%
102.51K to 107.51K
20-Jun-24 4:54 PM
View: 
Ma Stephen Hoi
Chief Financial Officer
Vickers Vantage Corp. I (SCLX) 20-Jun-24Option Exercise 2,000$1.41$2,820.0014%
14.14K to 16.14K
14-Jun-24 4:02 PM
View: 
Shah Jaisim
See Remarks
Director
Vickers Vantage Corp. I (SCLX) 14-Jun-24Option Exercise 33,333$1.41$46,999.5021%
155.88K to 189.22K
17-May-24 6:41 PM
View: 
Chun Jay
Director
Vickers Vantage Corp. I (SCLX) 17-May-24Purchase 57,500$0.90$51,640.80128%
45.01K to 102.51K
17-May-24 4:29 PM
View: 
Ma Stephen Hoi
Chief Financial Officer
Vickers Vantage Corp. I (SCLX) 17-May-24Purchase 14,140$0.88$12,443.20100%
0 to 14.14K
17-May-24 6:42 PM
View: 
Ji Henry
Executive Chairperson
Director
Vickers Vantage Corp. I (SCLX) 17-May-24Purchase 50,000$0.88$43,985.008%
606.0K to 656.0K
17-May-24 5:36 PM
View: 
Shah Jaisim
See Remarks
Director
Vickers Vantage Corp. I (SCLX) 17-May-24Purchase 56,939$0.92$52,099.2058%
98.94K to 155.88K
17-May-24 5:36 PM
View: 
Shah Jaisim
See Remarks
Director
Vickers Vantage Corp. I (SCLX) 16-May-24Purchase 83,061$0.84$69,846.00523%
15.88K to 98.94K
25-Sep-23 4:27 PM
View: 
Sorrento Therapeutics, Inc.
10% Owner
Vickers Vantage Corp. I (SCLX) 21-Sep-23Sale 60,068,600----(97%)
61.99M to 1.92M
20-Mar-23 5:19 PM
View: 
Ji Henry
Executive Chairperson
Director
Vickers Vantage Corp. I (SCLX) 17-Mar-23Acquisition (other) 2,730$8.60$23,478.50< 1%
603.3K to 606.03K
23-Jan-23 4:11 PM
View: 
Sorrento Therapeutics, Inc.
10% Owner
Vickers Vantage Corp. I (SCLX) 19-Jan-23Disposition (other) 73,740,800----(54%)
135.73M to 61.99M